27 Oct 2018
28 Oct 2018
Register now
Event location
North Western Melbourne PHN - Yarra Room
Level 5, 369 Royal Parade
Available to
General Practitioners
Professional development points
The HIV s100 Prescriber course is designed to support GPs in initiating and managing PLHIV in general practice and provide the opportunity for participants to establish relationships with local specialist services for ongoing mentoring and referral.

Day One: Saturday October 27th, 2018 - 8:30am - 5:00pm
Day Two: Sunday October 28th, 2018 - 8:30am - 4:15pm

Location: North Western Melbourne PHN - 369 Royal Parade Parkville

This course is held over two days (13 hours) as a face to face course, and will cover modules surrounding ARV therapy, screening and monitoring, toxicities and adverse effects, special scenarios, and clinical skills development.


Doctor Olga Vujovic
An Infectious Diesease Physician at the Alfred Hospital 
Dr Emma Paige 
An Infectious Disease Physician at The Alfred Hospital.
Prof Jennifer Hoy 
The Director of the Victorian HIV Service, Infectious Diseases Unit, The Alfred Hospital/Monash University.
Dr Matt Penn
An s100 HIV GP prescriber who works at the Centre Clinic, PRONTO and North Richmond Community Health.
Dr Nick Silberstein 
An s100 HIV GP prescriber who works at the Centre Clinic, North Richmond Community Health and Pronto

Travel Grants:
Travel grants may be provided to GPs in rural and remote Victoria to attend the course and become a HIV s100 prescriber. For more information please contact:  

Please note this course is funded by the Victorian State Govt and interstate participants are welcome to attend subject to space. A $660 fee will apply for all interstate participants. 

Learning outcomes

  • Describe the principles of initiation of antiretroviral therapy
  • Evaluate the complexity of factors influencing patients’ treatment decisions
  • Develop a clinical management plan for a patient on therapy, incorporating strategies for health promotion and harm minimization
  • Describe the contributing factors to the development of treatment toxicities and antiretroviral resistance
  • Identify appropriate referral pathways for complex HIV issues including salvage therapy, women considering pregnancy and IRIS